Epidemiological studies have shown that dietary factors are important in the etiology of colon cancer. High intake of fat, which elevates secretion of fecal bile acids, correlates with high incidence of colon cancer. 1, 2) This dietary habit in Western people results in a higher incidence of colon cancer and higher levels of fecal bile acids than in other peoples.
3) Secondary bile acids, such as lithocholic acid (LCA), promote tumorigenesis induced in rats by a monoalkylating agent, N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). 4, 5) LCA exerts its activity without further modification by the intestinal bacteria 6) but the molecular mechanism of the cancer-promoting activity of this bile acid remains obscure. LCA is derived from a primary bile acid, chenodeoxycholic acid (CDCA), via deconjugation of the glycine or taurine group at C-24 and dehydroxylation at C-7 by the action of intestinal bacteria (Fig.1) . In general, most of the primary, and part of the secondary bile acids and their salts are reabsorbed in the ileum, entering the enterohepatic circulation. However, LCA is poorly absorbed and is concentrated in colon, appearing at levels of up to 200 µM or more in feces. 7) Colon cancer is the result of the accumulation of mutations in a single colon epithelial cell. 8, 9) Indeed, bile acids/salts have been reported as putative DNA-damaging agents. For instance, LCA produces DNA single-strand breaks in mouse L1210 cells. 10) All of CDCA, LCA, glycolithocholic acid (GLCA) and taurolithocholic acid bind covalently to naked DNA in vitro.
11) These studies have provided a possible mechanism for the tumor-initiating activity of bile acids, via formation of DNA adducts, but they may not explain the tumor-promoting activity of LCA.
Recently, Sobol et al. 12) have demonstrated that mammalian DNA polymerase β (pol β) plays an essential role in the repair of damage caused by DNA-monomethylating agents such as MNNG or methyl methanesulfonate (MMS). In this context, we considered that mammalian DNA polymerases, especially pol β, might be a putative target of bile acids. Among five DNA polymerases in eukaryotic cells, 13) pol α, δ, and ε are expressed in proliferating cells and participate in chromosomal DNA replication, whereas pol γ plays a role in mitochondrial DNA replication. 14) Pol ε may also play a role in UV-induced 4 Correspondence to: Laboratory of Cancer Cell Biology, Research Institute for Disease Mechanism, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550. Abbreviations: pol α, DNA polymerase α; pol β, DNA polymerase β; pol γ, DNA polymerase γ; pol δ, DNA polymerase δ; pol ε, DNA polymerase ε; DTT, dithiothreitol; MMS, methyl methanesulfonate; DMSO, dimethyl sulfoxide; MNNG, Nmethyl-N′-nitro-N-nitrosoguanidine; LCA, lithocholic acid; CA, cholic acid; NaC, sodium cholate; CDCA, chenodeoxycholic acid; NaCDC, sodium chenodeoxycholate; DCA, deoxycholic acid; NaDC, sodium deoxycholate; GLCA, glycolithocholic acid; NaTLC, sodium taurolithocholate; NaTUDC, sodium tauroursodeoxycholate; NaTC, sodium taurocholate; NaGC, sodium glycocholate; NaTCDC, sodium taurochenodeoxycholate; NaGCDC, sodium glycochenodeoxycholate; NaTDC, sodium taurodeoxycholate; NaGDC, sodium glycodeoxycholate; NaLCS, sulfolithocholic acid sodium salt; Na 2 TLCS, sulfotaurolithocholic acid disodium salt; Na 2 GLCS, sulfoglycolithocholic acid disodium salt.
nucleotide excision repair. 13, 15) In contrast to these replicative polymerases, the expression of pol β seems to be constitutive in most tissues, and is up-regulated by monomethylating agents. 12, 16, 17) Disruption of the pol β gene in mouse cells induces the defect of short-patch DNA synthesis in base-excision repair. 12) In the present study, we have shown that, among various bile acids, only LCA strongly inhibits pol β activity. The characteristic accumulation of LCA in the colon 7) also supports the possibility that LCA promotes carcinogenesis in colon by inhibiting pol β.
MATERIALS AND METHODS
Chemicals Seventeen kinds of bile acids and their sodium salts were products of Sigma Chemical Co. (St. Louis, MO). These bile acids differ from each other at the C-3, C-7, C-12, and C-24 positions, shown as X, Y, Z, and COW in Fig. 1 . The compounds were dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 mM, and diluted with distilled water just before use. Enzymes We purified pol α from calf thymus by immunoaffinity-column chromatography as described previously. 18) Rat pol β was a gift from Dr. A. Matsukage, Nagoya, obtained from Escherichia coli carrying rat pol β-cDNA recombinant plasmid. 19) Pol γ was purified from bovine liver mitochondria. 20) Both pol δ and pol ε were from rat regenerating liver at 48 h after partial hepatectomy.
21)
DNA polymerase assays Pol α activity (0.2 unit) was assayed in a reaction mixture (25 21) In all cases, incubation was carried out at 37°C for 30 min and the acid-insoluble radioactivity was measured as described previously. 22) For kinetic analysis, the concentration of template-primer or [ 3 H]dTTP was variable. Inhibition assay Inhibitory effects of bile acids/salts on pol α, β, and γ were measured using activated calf thymus DNA as a template-primer. Chemically synthesized template-primers were used in the cases of pol δ and pol ε. Various concentrations of bile acids were prepared in 5% DMSO, and a 5 µl aliquot was mixed with 5 µl of DNA polymerase preparation, followed by preincubation at 0°C for 20 min. The reaction was started by the addition of the reaction mixture (15 µl) to give the final concentrations of constituents as described above. Concentrations of the bile acids are indicated as final concentrations in the reaction mixtures.
RESULTS AND DISCUSSION
Importance of dehydroxylation at C-7 and C-12 for inhibitory activities of bile acids/salts on DNA polymerases Among 17 kinds of bile acids/salts, only LCA and its derivatives showed marked inhibition of DNA Fig. 1 . Chemical structures of the bile acids/salts examined. The upper panel shows the general structure of bile acids. The lower panel shows the positions of hydroxyl groups and carboxyl group in the four major unconjugated bile acids. Cholic acid (CA) has three hydroxyl groups at X (C-3α), Y (C-7α), and Z (C-12α). Chenodeoxycholic acid (CDCA) has two hydroxyl groups at X and Y. Deoxycholic acid (DCA) has two hydroxyl groups at X and Z. Lithocholic acid (LCA) has a hydroxyl group at X alone. Taurine-or glycine-conjugated forms of bile acids have an amide linkage at C-24 shown as COW. The sulfated form of LCA has a sulfate group at X. Ursodeoxycholic acid has two hydroxyl groups at C-7β and X. Taurine-conjugated and glycine-conjugated (at C-24) forms of CA, CDCA, and DCA were compared with their deconjugated forms. Taurine-conjugated and glycine-conjugated (at C-24) forms of both LCA and sulfated LCA were also compared with their deconjugated forms. NaC, sodium cholate; NaTC, sodium taurocholate; NaGC, sodium glycocholate; CDCA, chenodeoxycholic acid; NaCDC, sodium chenodeoxycholate; NaTCDC, sodium taurochenodeoxycholate; NaGCDC, sodium glycochenodeoxycholate; NaDC, sodium deoxycholate; NaTDC, sodium taurodeoxycholate; NaGDC, sodium glycodeoxycholate; LCA, lithocholic acid; GLCA, glycolithocholic acid; NaLCS, sulfolithocholic acid sodium salt; NaTLC, sodium taurolithocholate; Na 2 TLCS, sulfotaurolithocholic acid disodium salt; Na 2 GLCS, sulfoglycolithocholic acid disodium salt; NaTUDC, sodium tauroursodeoxycholate. a) C-24 taurine conjugate. b) C-24 glycine conjugate. c) C-3 sulfate. d) Percent activity based on dTTP incorporation in the absence of the bile acids as 100%. Fig. 2 . Inhibition of DNA polymerases by LCA. Activities of pol α ( ), β ( ), γ ( ), δ ( ), and ε ( ) were measured in the presence of LCA ( Fig. 2A) or NaTLC (Fig. 2B ) at final concentrations of 10 µM to 100 µM as described in "Materials and Methods." Deoxy-TTP incorporation in the absence of each bile acid was taken as 100%.
polymerase activities at 100 µM (Table I) . LCA lacks hydroxyl groups at C-7α and C-12α, in contrast to other bile acids (Fig. 1) , and this peculiar structure may be important for its inhibitory activity. Among taurine-conjugated bile acids/salts, only sodium taurolithocholate (NaTLC) showed inhibition of pol β. Sodium tauroursodeoxycholate (NaTUDC), having a hydroxyl group at C-7β, showed no inhibition, although it lacks hydroxyl groups at C-7α and C-12α like LCA. Thus, dehydroxylation at C-7 (both α and β) and at C-12α may be essential for the inhibition. On the other hand, the structures at C-3 and C-24 may be less important, because LCA derivatives conjugated with glycine or taurine at these positions also showed the inhibition, though to a lesser extent. Previously, we showed that the sulfate group of sialic acid-containing glycolipid is indispensable for the inhibition of pol α. 23) In the cases of LCA and its derivatives, however, the absence of a sulfate group at C-3 did not negate, but rather enhanced the inhibitory effect on pol β (Table I) . Enzyme specificity in inhibition by LCA As shown in Fig. 2A , LCA inhibited the reaction of pol β most strongly (ID 50 =15 µM), though it also inhibited pol α at higher concentrations (ID 50 =50 mM). On the other hand, LCA inhibited pol γ and pol ε to a lesser extent, and did not inhibit pol δ. NaTLC, a sodium salt of taurine-conjugated LCA, inhibited pol β more weakly than LCA, but inhibited both pol α and pol γ as strongly as LCA (Fig.  2B) . Kinetic analysis of the inhibition of pol β β β β by LCA Lineweaver-Burk plots showed that the inhibition mode of pol β by LCA was non-competitive with respect to template-primer, and competitive with dTTP substrate (Fig. 3,  A and B) . The Ki value was estimated at 10 µM from the Dixon plot (Fig. 3C) . Competitive inhibition of pol β by LCA with substrate dTTP most probably indicates that LCA interacts with the dTTP-binding site of pol β, though the chemical structure of LCA is quite divergent from that of dTTP. A large divergence between the structures of competitive inhibitor and substrate is also observed in aphidicolin, a potent inhibitor of mammalian pol α, δ and ε 13) . Aphidicolin inhibits these three DNA replicative polymerases competitively with respect to dCTP (and/or dTTP) 24, 25) presumably by interacting with the side chains of amino acids within the highly conserved region I-II (dNTP-binding site). 13, [25] [26] [27] As a nonnucleotide type inhibitor, like aphidicolin, LCA could be useful to characterize the active site of pol β. Conclusion The strong inhibition of pol β by LCA presented here, combined with recent studies indicating direct involvement of pol β in base-excision repair, 12) suggests that LCA may suppress the repair of DNA damage caused by monoalkylating agents via the inhibition of pol β. The inhibition of base-excision repair by LCA could be correlated with its tumor-promoting activity in rat colon cancer induced by MNNG. 4) DNA methylation can be repaired either by base-excision repair or via the O 6 -methylguanine-DNA methyltransferase pathway. 28) Since O 6 -methylguanine DNA adducts are rather minor among methylated DNA adducts, 29) the O 6 -methylguanine-DNA methyltransferase pathway may not be as efficient as base-excision in the repair of methylated bases. We have found that a potent pol β inhibitor enhanced the mortality of human leukemic cells treated with a sublethal dose of MMS, but did not affect the mortality following UV irradiation.
30) Therefore, the high incidence of colon cancer in human populations with high concentrations of secondary bile acids could be explained in terms of the pol β inhibition by LCA. Another tumor promoter of colon cancer, 5) DCA, did not inihibit pol β. Therefore, DCA may act as a tumor promoter through a different mechanism. The interference with the repair pathway would cause cell death or enhance mutation incidence. Inhibition of DNA repair, in combination with endogenous or exogenous DNA damage, would enhance cytotoxicity and mutation frequency, which may result in carcinogenesis. For instance, xeroderma pigmentosum, an autosomal recessive disorder lacking the capacity of nucleotide-excision repair is accompanied with a high incidence of skin cancer when patients are exposed to UV. 31) Inhibitors of repair systems may act as a special class of tumor promoters, that would force plural mutations in a single cell after the initiation events, leading to the development of malignant cancer cells.
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